References
Christiansen J, Holst JJ, Kalaja E (1976) Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon. Gastroenterology70, 688–692.
Konturek SJ, Biernat J, Kwiecién N & Oleksy J (1975) Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology68, 448–454.
Bataille D, Gespach C, Tatemoto K, Marie J-C, Coudray A-M, Rosselin G & Mutt V (1981) Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities. Peptides2, Suppl. 2, 41–44.
Bataille D, Tatemoto K, Coudray A-M, Carlqvist M, Rosselin G & Mutt V (1982) Isolation and chemical characterization of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum.4th Int. Symposium on Gastrointestinal Hormones, Stockholm, June 1982, in press.
Bataille D, Gespach C, Coudray A-M, & Rosselin G (1981) ‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action. Biosci. Rep.1, 151–155.
Robein MJ, De La Mare M-C, Dubrasquet M & Bonfils S (1979) Utilization of the perfused stomach in anesthetized rats to study the inhibitory effect of somatostatin in gastric acid secretion. Agents Actions9, 415–421.
Lai KS (1964) Studies of gastrin. Part 1: A method of biological assay of gastrin. Gut5, 327–333.
Gespach C, Bataille D, Dutrillaux M-C & Rosselin G (1982) The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems in rat gastric glands. Biochim. Biophys. Acta720, 7–16.
Ivey K, Tarnavski A, Sherman D, Krause WJ, Ackman K, Burks M & Hewett J (1980) Quantitative ultrastructural analysis of the human parietal cell during acid inhibtion and increase of gastric potential difference by glucagon. Gut21, 3–8.
Wilson DE, Ginsberg B, Levine RA & Washington A (1972) Effect of glucagon on histamine-and pentagastrin-stimulated canine gastric acid secretion and mucosal blood flow. Gastroenterology61, 45–50.
Christiansen J, Bech A, Fahrenkrug J, Holst JJ, Lauritsen K, Moody AJ & Schaffalitzky de Muckadell O (1979) Fat-induced jejunal inhibiton of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide and vasoactive intestinal polypeptide in man. Scand. J. Gastroenterol.14, 161–166.
Munck A, Bataille D, Marie JC & Rosselin G (1982) Glucagon-related peptides in human bowel: quantitative evaluation by HPLC-radioreceptor assay. Evidence for the presence of glucagon-37 (oxyntomodulin/bioactive enteroglucagon) and glucagon-29 (pancreatic glucagon).4th Int. Symposium on Gastrointestinal Hormones. Stockholm, June 1982 (in press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dubrasquet, M., Bataille, D. & Gespach, C. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in rats. Biosci Rep 2, 391–395 (1982). https://doi.org/10.1007/BF01119301
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01119301